BioSante Pharmaceuticals biosantepharma.com


Public list: Womens Health Startups (462) Pharma Startups (4740)

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. BioSante's key products are LibiGel® (testosterone gel) in Phase III clinical development under an SPA, to treat female sexual dysfunction, and Elestrin (estradiol gel), FDA approved to treat hot flashes in menopausal women. The current market for testosterone and estrogen products is approximately $2.5 billion dollars in the U.S. alone, with...Show all

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. BioSante's key products are LibiGel® (testosterone gel) in Phase III clinical development unde...Show all

Company (Alive / Active)

Phone: 847-478-0500

Fax:

111 Barclay Boulevard

Lincolnshire, 60069
Illinois, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
BioSante Pharmaceuticals $36.3M Jun 14, 2007
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related BioSante Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 33 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

ARIAD Pharmaceuticals

Cambridge, Massachusetts, United States
AcquiredARIAD is developing breakthrough medicines that regulate cell-signaling pathways implicated in cancer. Our pipeline includes a series of small molecule product candidates that provide targeted and highly potent anti-cancer activity to treat solid tumors and hematologic cancers, as well as the spread of tumors to distant sites. Our lead candidate �� ridaforolimus, a novel mTOR inhibitor �� has been given fast trac...Show allLogin to see details

DiObex

San Francisco, California, United States
Dead / InactiveDiObex is a biopharmaceutical company that has one of the lead compounds for the treatment of type 2 diabetes via the innovative cortisol pathway in clinical testing. This new mechanism of action might also lead to the prevention of metabolic syndrome. Their pipeline includes products targeted at medical needs in metabolic disorders including type 1 diabetes, dyslipidemia, obesity, and diabetic nephropathy.Login to see details
See all 15 competitors